These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12538686)

  • 1. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
    Denkinger CM; Denkinger M; Kort JJ; Metz C; Forsthuber TG
    J Immunol; 2003 Feb; 170(3):1274-82. PubMed ID: 12538686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
    Hofstetter HH; Shive CL; Forsthuber TG
    J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis.
    Targoni OS; Baus J; Hofstetter HH; Hesse MD; Karulin AY; Boehm BO; Forsthuber TG; Lehmann PV
    J Immunol; 2001 Apr; 166(7):4757-64. PubMed ID: 11254738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.
    Fife BT; Kennedy KJ; Paniagua MC; Lukacs NW; Kunkel SL; Luster AD; Karpus WJ
    J Immunol; 2001 Jun; 166(12):7617-24. PubMed ID: 11390519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.
    Fagone P; Mazzon E; Cavalli E; Bramanti A; Petralia MC; Mangano K; Al-Abed Y; Bramati P; Nicoletti F
    J Neuroimmunol; 2018 Sep; 322():46-56. PubMed ID: 29935880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
    Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.
    Howard LM; Miller SD
    J Immunol; 2001 Feb; 166(3):1547-53. PubMed ID: 11160195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
    Luca ME; Kel JM; van Rijs W; Wouter Drijfhout J; Koning F; Nagelkerken L
    J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    Nath N; Giri S; Prasad R; Singh AK; Singh I
    J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
    Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
    J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.
    Croxford JL; Anger HA; Miller SD
    J Immunol; 2005 Jan; 174(2):907-17. PubMed ID: 15634913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
    Kohm AP; Carpentier PA; Anger HA; Miller SD
    J Immunol; 2002 Nov; 169(9):4712-6. PubMed ID: 12391178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
    Furlan R; Kurne A; Bergami A; Brambilla E; Maucci R; Gasparini L; Butti E; Comi G; Ongini E; Martino G
    J Neuroimmunol; 2004 May; 150(1-2):10-9. PubMed ID: 15081244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
    Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
    J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
    Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
    J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
    Natarajan C; Bright JJ
    J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.